HEV ORF2 and ORF3 Ag Protein |
abx060578-1mg |
Abbexa |
1 mg |
EUR 1830 |
|
Hbsag Assay Laboratories manufactures the hbs ag reagents distributed by Genprice. The Hbs Ag reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact hbsag assay. Other Hbs products are available in stock. Specificity: Hbs Category: Ag
Dog True insulin ELISA kit |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Biology information
AG-14361 |
27602-1 |
BPS Bioscience |
5 mg |
EUR 205 |
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG-14361 |
27602-2 |
BPS Bioscience |
10 mg |
EUR 360 |
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG-14361 |
27602-3 |
BPS Bioscience |
50 mg |
EUR 825 |
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG-126 |
C4338-10 |
ApexBio |
10 mg |
EUR 289.2 |
Description: IC50: inhibits the phosphorylation of ERK1 and ERK2 at 25-50 ?MAG-126 is an ERK1 and ERK2 inhibitor. |
AG-126 |
C4338-25 |
ApexBio |
25 mg |
EUR 582 |
Description: IC50: inhibits the phosphorylation of ERK1 and ERK2 at 25-50 ?MAG-126 is an ERK1 and ERK2 inhibitor. |
AG-126 |
C4338-5 |
ApexBio |
5 mg |
EUR 184.8 |
Description: IC50: inhibits the phosphorylation of ERK1 and ERK2 at 25-50 ?MAG-126 is an ERK1 and ERK2 inhibitor. |
AG-1557 |
C5417-10 |
ApexBio |
10 mg |
EUR 247.2 |
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases. |
AG-1557 |
C5417-25 |
ApexBio |
25 mg |
EUR 502.8 |
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases. |
AG-1557 |
C5417-5 |
ApexBio |
5 mg |
EUR 158.4 |
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases. |
AG-1557 |
C5417-50 |
ApexBio |
50 mg |
EUR 847.2 |
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases. |
AG-1295 |
C5465-10 |
ApexBio |
10 mg |
EUR 309.6 |
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. |
AG-1295 |
C5465-25 |
ApexBio |
25 mg |
EUR 582 |
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. |
AG-1295 |
C5465-5 |
ApexBio |
5 mg |
EUR 195.6 |
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. |
AG-041R |
C4101-10 |
ApexBio |
10 mg |
EUR 540 |
Description: AG-041R is a cholecystokinin-B/gastrin receptor (Gastrin/CCK-B) antagonist [1]. The Gastrin/CCK-B receptor is a regulator of gastric acid secretion and mucosal growth. |
AG-041R |
C4101-5 |
ApexBio |
5 mg |
EUR 331.2 |
Description: AG-041R is a cholecystokinin-B/gastrin receptor (Gastrin/CCK-B) antagonist [1]. The Gastrin/CCK-B receptor is a regulator of gastric acid secretion and mucosal growth. |
AG-041R |
C4101-50 |
ApexBio |
50 mg |
EUR 2164.8 |
Description: AG-041R is a cholecystokinin-B/gastrin receptor (Gastrin/CCK-B) antagonist [1]. The Gastrin/CCK-B receptor is a regulator of gastric acid secretion and mucosal growth. |